Complications of Endoscopic Retrograde Cholangiopancreatography. Avoidance and Management

Gastrointestinal Endoscopy Clinics of North America

Volumn 22, Issue 3, 2012, Pages 567-586

  Freeman, Martin L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Complications; Endoscopic retrograde cholangiopancreatography; ERCP; Hemorrhage; Perforation; Post ERCP pancreatitis

Indexed keywords

ADRENALIN; GABEXATE; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; SOMATOSTATIN;

CARDIOVASCULAR DISEASE; CAUTERIZATION; CHOLANGITIS; CHOLECYSTITIS; DRUG EFFICACY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; INTESTINE PERFORATION; LUNG DISEASE; OUTCOME ASSESSMENT; PANCREATIC STENT; PANCREATITIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; REVIEW; SPHINCTEROTOMY; STENT; SURGICAL RISK; UTERINE TAMPONADE;

CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGITIS; CHOLECYSTITIS; CLINICAL COMPETENCE; COLONIC DISEASES; HEMORRHAGE; HUMANS; INTESTINAL PERFORATION; PANCREATITIS; SPHINCTEROTOMY, ENDOSCOPIC; STENTS;

EID: 84862998564     PISSN: 10525157     EISSN: 15581950     Source Type: Journal    
DOI: 10.1016/j.giec.2012.05.001     Document Type: Review

References (44)

1. Cotton P.B., Lehman G., Vennes J.A., et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991, 37:383-391.
2. Freeman M.L., Nelson D.B., Sherman S., et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996, 335:909-918.
3. Freeman M.L., DiSario J.A., Nelson D.B., et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 2001, 54:425-434.
4. Cheng C.L., Sherman S., Watkins J.L., et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol 2006, 101:139-147.
5. Vandervoort J., Soetikno R.M., Tham T.C., et al. Risk factors for complications after performance of ERCP. Gastrointest Endosc 2002, 56:652-656.
6. Masci E., Toti G., Mariani A., et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 2001, 96:417-423.
7. Loperfido S., Angelini G., Benedetti G., et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998, 48:1-10.
8. Wang P., Li Z.S., Liu F., et al. Risk factors for ERCP-related complications: a prospective multicenter study. Am J Gastroenterol 2009, 104:31-40.
9. Williams E.J., Taylor S., Fairclough P., et al. Risk factors for complication following ERCP: results of a large-scale, prospective multicenter study. Endoscopy 2007, 9:793-802.
10. Masci E., Mariani A., Curioni S., et al. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis. Endoscopy 2003, 35:830-834.
11. Trap R., Adamsen S., Hart-Hansen O., et al. Severe and fatal complications after diagnostic and therapeutic ERCP: a prospective series of claims to insurance covering public hospitals. Endoscopy 1999, 31:125-130.
12. Cennamo V., Fuccio L., Rocco M., et al. Can a wire-guided cannulation technique increase bile duct cannulation rate and prevent post-ERCP pancreatitis?: A meta-analysis of randomized controlled trials. Am J Gastroenterol 2009, 104:2343-2350.
13. Singh P., Gurudu S.R., Davidoff S., et al. Sphincter of Oddi manometry does not predispose to post-ERCP acute pancreatitis. Gastrointest Endosc 2004, 59:499-505.
14. Andriulli A., Loperfido S., Napolitano G., et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol 2007, 102:1781-1788.
15. Freeman M.L., Guda N.L. Cannulation techniques for ERCP: a review of reported techniques. Gastrointest Endosc 2005, 61:112-125.
16. Fogel E.L., Eversman D., Jamidar P., et al. Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone. Endoscopy 2002, 34:280-285.
17. Cennamo V., Fuccio L., Zagari R.M., et al. Can early precut implementation reduce endoscopic retrograde cholangiopancreatography-related complication risk? Meta-analysis of randomized controlled trials. Endoscopy 2010, 42:381.
18. Freeman M.L. Pancreatic stents for prevention of post-ERCP pancreatitis: for everyday practice or for experts only?. Gastrointest Endosc 2010, 71:940-944.
19. Tarnasky P., Palesch Y., Cunningham J., et al. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998, 115:1518-1524.
20. Fazel A., Quadri A., Catalano M.F., et al. Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study. Gastrointest Endosc 2003, 57:291-294.
21. Singh P., Das A., Isenberg G., et al. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials. Gastrointest Endosc 2004, 60:544-550.
22. Harewood G.C., Pochron N.L., Gostout C.J. Prospective, randomized, controlled trial of prophylactic pancreatic stent placement for endoscopic snare excision of the duodenal ampulla. Gastrointest Endosc 2005, 62:367-370.
23. Freeman M.L., Overby C.S., Qi D.F. Pancreatic stent insertion: consequences of failure, and results of a modified technique to maximize success. Gastrointest Endosc 2004, 59:8-14.
24. Sofuni A., Maguchi H., Mukai T., et al. Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients. Clin Gastroenterol Hepatol 2011, 9:851-858.
25. Freeman M.L. Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol 2007, 5:1354-1365.
26. Choudhary A., Bechtold M.L., Arif M., et al. Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review. Gastrointest Endosc 2011, 73:275-282.
27. Mazaki T., Masuda H., Takayama T. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy 2010, 42:842-853.
28. Smith M.T., Sherman S., Ikenberry S.O., et al. Alterations in pancreatic ductal morphology following polyethylene pancreatic stent therapy. Gastrointest Endosc 1996, 44:268-275.
29. Kozarek R.A. Pancreatic stents can induce ductal changes consistent with chronic pancreatitis. Gastrointest Endosc 1990, 36:93-95.
30. Rashdan A., Fogel E.L., McHenry L., et al. Improved stent characteristics for prophylaxis of post-ERCP pancreatitis. Clin Gastroenterol Hepatol 2004, 2:322-329.
31. Bakman Y.G., Safdar K., Freeman M.L. Pancreatic stent-induced ductal injury: clinical implications and outcomes of endoscopic therapy. Endoscopy 2009, 41:1095-1098.
32. Disario J.A., Freeman M.L., Bjorkman D.J., et al. Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones. Gastroenterology 2004, 127:1291-1299.
33. Baron T.H., Harewood G.C. Endoscopic balloon dilation of the biliary sphincter compared to endoscopic biliary sphincterotomy for removal of common bile duct stones during ERCP: a metaanalysis of randomized, controlled trials. Am J Gastroenterol 2004, 99:1455-1460.
34. Attam R., Freeman M.L. Endoscopic papillary large balloon dilation for large common bile duct stones. J Hepatobiliary Pancreat Surg 2009, 16:618-623.
35. Freeman M.L., Guda N.M. Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointest Endosc 2004, 59:845-864.
36. Elmunzer B.J., Waljee A.K., Elta G.H., et al. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut 2008, 57:1262-1267.
37. Elmunzer B.J., Scheiman J.M., Lehman G.A., et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med 2012, 366:1414-1422.
38. Madacsy L., Kurucsai G., Joo I., et al. ERCP and insertion of a small-caliber pancreatic stent to prevent the evolution of severe post-ERCP pancreatitis: a case-controlled series. Surg Endosc 2009, 23:1887-1893.
39. Enns R., Eloubeidi M.A., Mergener K. ERCP-related perforations: risk factors and management. Endoscopy 2002, 34:293-298.
40. Howard T.J., Tan T., Lehman G.A., et al. Classification and management of perforations complicating endoscopic sphincterotomy. Surgery 1999, 126(4):658-663.
41. Harris A., Chan A.C., Torres-Viera C., et al. Meta-analysis of antibiotic prophylaxis in endoscopic retrograde cholangiopancreatography (ERCP). Endoscopy 1999, 9:718-724.
42. Kapral C., Duller C., Wewalka F., et al. Case volume and outcome of endoscopic retrograde cholangiopancreatography: results of a nationwide Austrian benchmarking project. Endoscopy 2008, 40:625-631.
43. Masci E., Minoli G., Rossi M., et al. Prospective multicenter quality assessment of endotherapy of biliary stones: does center volume matter?. Endoscopy 2007, 39:1076-1081.
44. Guda N.M., Freeman M.L. How many ERCPs should you do to not harm your patients?. Endoscopy 2008, 40:675-676.